Pfizer hopes to nose out competition with approval for new migraine nasal spray Zavzpret
Fierce Pharma
MARCH 10, 2023
Pfizer hopes to nose out competition with approval for new migraine nasal spray Zavzpret kdunleavy Fri, 03/10/2023 - 10:22
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Fierce Pharma
MARCH 10, 2023
Pfizer hopes to nose out competition with approval for new migraine nasal spray Zavzpret kdunleavy Fri, 03/10/2023 - 10:22
Fierce Pharma
SEPTEMBER 16, 2022
Novartis headquarters raided in Swiss competition authority's patent probe. Thu, 09/15/2022 - 10:15.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 25, 2022
Merck fined $38M in Spain for hindering generic competition for NuvaRing. Tue, 10/25/2022 - 11:18.
pharmaphorum
DECEMBER 14, 2022
But increased competition is on the horizon. Competition starts to heat up. In a case filed in California in 2021, Molina Healthcare claimed Jazz Pharmaceuticals engaged in a “comprehensive anticompetitive scheme to suppress generic competition for Xyrem,” abused the REMS program, and “engaged in sham patent litigation.”.
Healthcare Success
JUNE 6, 2022
What’s more, your highest revenue service lines are likely already facing stiff competition from all angles. . For these reasons and more, it’s imperative to identify your unique selling propositions, review them, and revise them regularly to remain competitive. . So, how can your brand stay competitive? The answer is twofold.
pharmaphorum
OCTOBER 7, 2022
It’s often stated – mostly without reference to data – that the environment for innovative launches is more competitive now than it ever has been. Continued competitive intensity. The first in class launches barely have time to establish before they face competition, and then the competition keeps on coming.
MedCity News
APRIL 3, 2023
The agency said Illumina’s proposed remedies are insufficient and the tie-up is likely to reduce competition in the R&D and commercialization of new cancer tests. The Federal Trade Commission has ordered Illumina to divest Grail, the liquid biopsy company it acquired for more than $7 billion.
Copyright Clearance Center
MARCH 3, 2023
The post PRH Restructures, Readies for Future Competition appeared first on Copyright Clearance Center.
European Pharmaceutical Review
NOVEMBER 25, 2022
Should LY03010 receive US Food and Drug Administration (FDA) approval, Luye Pharma will need to provide solid marketing and competitive pricing to set it apart from competitors and convince payers to reimburse it.”. The post Promising schizophrenia drug faces tough competition appeared first on European Pharmaceutical Review.
European Pharmaceutical Review
OCTOBER 14, 2022
Amgen’s 2022 market report has detailed how competition has driven savings across healthcare, estimating that a considerable number of biologics will be in competition with biosimilars in five to 10 years. A rise in savings per quarter was recognised in this year’s data.
PM360
MARCH 9, 2023
This industry is brimming with creative talent—both in what they do for their jobs and for themselves. To highlight the latter, every year PM360 asks for submissions of original artwork from those who work in the industry, and we pick our favorite piece to serve as the cover of our Greatest Creators section.
Medical Sales Guru
APRIL 20, 2021
Medical sales representatives are often advised to target the competition. If you’re in medical sales, the competition isn’t your problem…It’s the customer! Medical sales representatives are often advised to target the competition. I tell you why in this short video and what you should do to address it.
Pharmaceutical Technology
JANUARY 25, 2023
Despite this, Spikevax’s average annual sales forecast has plummeted by 23% between H1 and H2 2022 according to GlobalData’s Coronavirus Disease 2019 (COVID-19) Sector Forecast reports, due to increasing competition from Pfizer’s Comirnaty, Novavax’s Nuvaxovid, and Covid-19 therapeutics.
MedCity News
AUGUST 17, 2022
The move means Sanofi is out of the competitive chase to develop a so-called “oral SERD” therapy for patients with a certain type of breast cancer. Sanofi breast cancer drug amcenestrant has failed in a Phase 3 clinical trial, leading the pharmaceutical giant to discontinue all clinical development of the small molecule.
Medical Sales Authority
OCTOBER 28, 2022
Medical device sales is a competitive industry. Second, it means there is fierce competition once you land a job. The competitive spirit comes alive when there is good money to be made. To truly succeed in the industry you have to understand how to beat the competition. How Competitive Is Medical Device Sales?
Contrarian Sales Techniques
JANUARY 23, 2023
Gathering information on competitors In addition to conducting market research, sales representatives also need to be aware of the competition in the pharmaceutical industry. By understanding the strengths and weaknesses of the competition, a sales representative can develop a competitive advantage and stand out in the market.
Eversana Intouch
MARCH 31, 2023
It’s an exciting era in oncology: many new drugs with increasing benefits and more tolerable profiles are being developed and released, and that means that nearly all tumor type spaces are becoming more competitive.
MedReps
MAY 25, 2022
In addition to these skills, you also need to be able to be both competitive and professional in order to meet your sales goals. Balancing Your Competitive and Professional Sides as a Sales Rep. Remember that your main competition lies in the other companies that are making sales in your region – not your co-workers.
MedCity News
MAY 10, 2023
A drug developed by Protalix BioTherapeutics and Chiesi Group is now FDA approved for treating Fabry disease, a rare inherited metabolic disorder. The drug, Elfabrio, is an enzyme replacement therapy.
Pharmaceutical Technology
APRIL 20, 2023
This is one of several patent infringement cases Amgen has pursued in recent years to stave competition. Despite this legal win, Amgen still faces a competitive psoriasis market as other drugs enter the landscape. Patent No. 8, 093, 283 (the “’283 Patent”).
MedReps
SEPTEMBER 20, 2022
Whether it’s a similar product, prescription or piece of equipment, you need to know how to deal with medical sales competition in order to meet your sales goals. How can you deal with this competition? However, you need to go a few steps further in order to beat the competition. Final Thoughts on Medical Sales Competition.
Pharmaceutical Technology
SEPTEMBER 13, 2022
In addition to Enhertu, Trodelvy may also experience competition from Daiichi/AstraZeneca’s anti-TROP2 ADC, datopotamab deruxtecan (dato-DXd), which is being investigated in the Phase III TROPION-Breast01 trial for previously treated HR+/HER2- patients.
Clarivate
DECEMBER 19, 2022
Either way, competition over employed providers among Medicare Advantage plans has only begun to heat up and UnitedHealth remains the plan to beat. Medicare provider competition appeared first on Clarivate. To learn more about how Clarivate helps life science companies navigate the fast-changing U.S.
pharmaphorum
AUGUST 17, 2022
The latest life science competitiveness indicators (LSCIs) were published by the Office of Life Sciences (OLS) in July 2022. Indicators from the 2000s were captured in the Pharmaceutical Industry Competitiveness Task Force (PICTF) Indicators. The post UK life science competitiveness indicators 2022: measuring what matters most?
PharmaTech
FEBRUARY 15, 2023
Shifting toward more technological solutions and ensuring a greater understanding of the workforce’s needs will give both CROs and sponsors a market advantage.
Fierce Pharma
JUNE 2, 2023
As Bristol Myers Squibb braces for increasing generic competition this decade, the company is counting on its newer medicines to drive growth. | As Bristol's top-sellers creep toward the patent cliff, new launch Camzyos has picked up a key endorsement in England.
MedCity News
JANUARY 23, 2023
The FDA approved TheracosBio’s Brenzavvy as a treatment for type 2 diabetes. But before it won a regulatory nod for controlling blood glucose in adults, it was approved at a different dose (with flavor) as a veterinary product.
MedCity News
FEBRUARY 23, 2023
FDA approval of Sanofi hemophilia A drug Altuviiio provides patients with a therapeutic option that lasts longer than most other products available, including one already marketed by the French pharma giant. Altuviiio also gives Sanofi a way to better compete against blockbuster Roche drug Hemlibra.
PM360
MARCH 9, 2023
Every year we ask all of the amateur artists in our industry to send in their best pieces of original artwork for the chance to land on the cover of our Greatest Creators special section. This year, we selected “AI – Portrait Study #8” by Phil Winn, Lead Art Director, Evoke MicroMass as the winner.
MedCity News
DECEMBER 13, 2022
Amgen’s Lumakras became the first FDA-approved drug that addresses the elusive KRAS mutation, but Mirati believes its newly approved therapy, Krazati, could be better. The small molecule’s features include the ability to penetrate into the brain, where it can address cancer that has spread to the central nervous system.
Clarify Health
NOVEMBER 15, 2021
For health plans looking to grow their share of this market, they need to ensure that they’re as competitive as possible. For one national health plan, the strategy to improve and expand their Medicare Advantage networks was built upon meeting competitive overlap targets.
MobileLocker
NOVEMBER 25, 2020
The post Personalized Presentations Give Pharma and Med Tech Reps the Edge to Beat the Competition appeared first on MobileLocker. Find out how some simple customization techniques can help your sales presentations connect with clients and prospects.
Sales Pilot Medical Sales Performance
APRIL 20, 2021
The post In Medical Sales…Fear The Customer, Not The Competition first appeared on MEDICAL SALES TRAINING.
MedCity News
NOVEMBER 9, 2022
Telemedicine company TytoCare launched a new offering that promises to give providers and health plans the range of products and services needed to operate successful virtual primary care programs.
Pharmacy Times
AUGUST 18, 2022
Each year, the NCPA Annual Convention is able to showcase student business plans in a competition that correlates to a real life business plan.
Axxelus
DECEMBER 8, 2021
It’s hard to find qualified and motivated talent these days. When new talent is found for any given role, it can be incredibly difficult to keep that talent. This is a phenomenon that is affecting virtually every industry in the wake of the COVID-19 pandemic.
PharmExec
JUNE 24, 2022
Takes aim at actions that limit access to lower-cost drugs, calls for revamp of M&A-impact guidelines.
MedCity News
OCTOBER 18, 2022
Many have never heard of a pharmacy benefit manager, mega-profitable companies that control what consumers pay for prescription drugs. The FTC’s new probe needs to go far to change the status quo.
MedCity News
MAY 19, 2023
They alleged that the health system has prevented its workers from being able to advocate for themselves and their patients through “a draconian system of mobility restrictions and widespread labor law violations that lock in sub-competitive pay and working conditions.”
MedCity News
MAY 25, 2023
The competition saw 23 healthcare startups across biopharma, medical devices, and health tech geared for consumers/employers as well as payers/providers pitch their business plans to teams of investor judges.
MedCity News
MAY 16, 2023
But rather than claiming product overlap, the agency contends Amgen will use its influence to keep at bay competition for Horizon’s products. The Federal Trade Commission is suing to stop Amgen’s acquisition of Horizon Therapeutics.
Pharma Leaders
NOVEMBER 13, 2022
The Federal Trade Commission (FTC) has filed an amicus brief in the U.S. District Court for the District of Delaware arguing that some branded drug manufacturers have a history of using restricted distribution programs to delay the introduction of generic drugs.
pharmaphorum
JULY 22, 2022
Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. ” The post Pfizer, Flynn fined £70m in resurrected epilepsy drug pricing probe appeared first on.
InCrowd
APRIL 6, 2023
A well-known, established blockbuster brand at a top-10 pharma company needed a better solution for tracking its highly competitive market. Their traditional, data-heavy, time-consuming, and expensive ATU wasn’t meeting their needs.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content